This Upcoming Event Could Affect Sarepta Therapeutics Investors
March 18, 2015 at 14:09 PM EDT
Credit Suisse commented on Sarepta Therapeutics Inc (NASDAQ: SRPT) ahead of an FDA workshop on Friday titled "Measuring ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.